CYTOMX THERAPEUTICS INC's ticker is CTMX and the CUSIP is 23284F105. A total of 63 filers reported holding CYTOMX THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.10 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $913,278 | -27.0% | 707,968 | -2.7% | 0.00% | – |
| Q2 2023 | $1,251,092 | -41.3% | 727,380 | -48.5% | 0.00% | – |
| Q1 2023 | $2,131,206 | +85.9% | 1,411,394 | +96.9% | 0.00% | – |
| Q4 2022 | $1,146,634 | +12.7% | 716,646 | +2.1% | 0.00% | – |
| Q3 2022 | $1,017,000 | -21.0% | 701,572 | -0.2% | 0.00% | – |
| Q2 2022 | $1,287,000 | -31.3% | 703,209 | +0.2% | 0.00% | – |
| Q1 2022 | $1,874,000 | -19.3% | 701,817 | +30.8% | 0.00% | – |
| Q4 2021 | $2,322,000 | -56.4% | 536,435 | -48.7% | 0.00% | – |
| Q3 2021 | $5,322,000 | -19.6% | 1,045,620 | 0.0% | 0.00% | -100.0% |
| Q2 2021 | $6,619,000 | -18.1% | 1,045,620 | +0.0% | 0.00% | 0.0% |
| Q1 2021 | $8,082,000 | +18.0% | 1,045,607 | 0.0% | 0.00% | 0.0% |
| Q4 2020 | $6,849,000 | +24.9% | 1,045,607 | +26.8% | 0.00% | 0.0% |
| Q3 2020 | $5,485,000 | -20.6% | 824,907 | -0.5% | 0.00% | 0.0% |
| Q2 2020 | $6,906,000 | +8.7% | 828,973 | +0.0% | 0.00% | 0.0% |
| Q1 2020 | $6,355,000 | -7.7% | 828,613 | -0.0% | 0.00% | 0.0% |
| Q4 2019 | $6,885,000 | +5.5% | 828,618 | -6.3% | 0.00% | 0.0% |
| Q3 2019 | $6,529,000 | -56.0% | 884,726 | -33.1% | 0.00% | -50.0% |
| Q2 2019 | $14,847,000 | -35.4% | 1,323,211 | -38.1% | 0.00% | -33.3% |
| Q1 2019 | $22,992,000 | -74.3% | 2,138,779 | -63.9% | 0.00% | -75.0% |
| Q4 2018 | $89,458,000 | -28.3% | 5,924,431 | -12.2% | 0.01% | -14.3% |
| Q3 2018 | $124,774,000 | -6.6% | 6,744,553 | +15.4% | 0.01% | -6.7% |
| Q2 2018 | $133,586,000 | -18.9% | 5,843,626 | +0.9% | 0.02% | -25.0% |
| Q1 2018 | $164,774,000 | +35.5% | 5,791,673 | +0.5% | 0.02% | +42.9% |
| Q4 2017 | $121,621,000 | +21.0% | 5,761,294 | +4.2% | 0.01% | +16.7% |
| Q3 2017 | $100,482,000 | +17.6% | 5,530,105 | +0.3% | 0.01% | +9.1% |
| Q2 2017 | $85,444,000 | -9.7% | 5,512,459 | +0.6% | 0.01% | -8.3% |
| Q1 2017 | $94,600,000 | +57.6% | 5,477,727 | +0.3% | 0.01% | +50.0% |
| Q4 2016 | $60,009,000 | -29.7% | 5,460,352 | +0.3% | 0.01% | -27.3% |
| Q3 2016 | $85,350,000 | +54.4% | 5,443,262 | +0.6% | 0.01% | +37.5% |
| Q2 2016 | $55,295,000 | -20.8% | 5,413,165 | +0.0% | 0.01% | -20.0% |
| Q1 2016 | $69,811,000 | -38.1% | 5,411,681 | +0.1% | 0.01% | -33.3% |
| Q4 2015 | $112,773,000 | – | 5,403,643 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Aquilo Capital Management, LLC | 524,763 | $7,924,000 | 3.84% |
| Congress Park Capital LLC | 123,311 | $1,862,000 | 2.05% |
| Perceptive Advisors | 2,911,715 | $43,588,000 | 1.66% |
| RTW INVESTMENTS, LP | 908,586 | $13,720,000 | 1.28% |
| HAMILTON LANE ADVISORS LLC | 68,753 | $1,038,000 | 0.91% |
| HARBOURVEST PARTNERS LLC | 79,193 | $1,196,000 | 0.57% |
| SPHERA FUNDS MANAGEMENT LTD. | 273,151 | $4,125,000 | 0.46% |
| Exane Asset Management | 50,000 | $755,000,000 | 0.44% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 622,548 | $9,400,000 | 0.38% |
| Cormorant Asset Management, LP | 296,712 | $4,480,000 | 0.36% |